Product Description
Acemannan has various medicinal properties like osteogenic, anti-inflammatory, and antibacterial, which accelerate healing of lesions. Also, acemannan is known to have antiviral and antitumor activities in vivo through activation of immune responses. (Sourced from: https://pubmed.ncbi.nlm.nih.gov/25233608/)
Mechanisms of Action: TLR5 Agonist
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Oral, Topical
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Brazil
Approved Indications: None
Company: AceTech
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Candidiasis, Oral
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT04481802 |
RadiaAce001 | N/A |
Unknown status |
Radiodermatitis|Breast Cancer |
2022-07-01 |
2023-07-04 |
Primary Endpoints |
|
NCT03250923 |
IRB2017-0042 | P2 |
Unknown status |
Candidiasis, Oral |
2024-09-01 |
2025-05-03 |
Primary Endpoints|Treatments|Trial Status |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
10/08/2025 |
News Article |
SugarMute Announces Expanded Availability of Blood Sugar Support Formula with Updated Ingredient Research |
|
07/05/2021 |
News Article |
Motiva launches a 'life changing' product, the first-ever clinically proven to help improve Alzheimer's patients |
|
06/28/2021 |
News Article |
Motiva launches a 'life changing' product, the first-ever clinically proven to help improve Alzheimer's patients |
|
06/17/2020 |
News Article |
Alovéa Partners with Operation Underground Railroad |